We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Assay Detects Pathogenic Bacteria Concurrently

By LabMedica International staff writers
Posted on 19 Sep 2011
A real-time multiplex polymerase chain reaction (PCR) has been developed that identifies common diarrhea-causing bacteria in fecal samples.

Sets of primers and probes were designed that were specific for Campylobacter jejuni, Salmonella, Shigella/enteroinvasive Escherichia coli EIEC, and Yersinia species, suitable for use in a one-tube PCR assay. More...


Scientists at the Bernhard Nocht Institute (Hamburg, Germany) tested a total of 393 stool samples, submitted for routine culture of enteric pathogens that had been collected from 2007 to December 2008 from various institutions. The samples were obtained from patients with different qualities of diarrhea (watery and bloody), but none of them had a recent travel history. All samples were examined by conventional microbiological methods and subsequently by real-time multiplex PCR in a blinded manner. DNA was extracted from the stools using QIAamp DNA Stool Mini Kit and the real-time multiplex PCR was carried out on a RotorGene6000 Cycler, both obtained from Qiagen (Hilden, Germany).

The PCR yielded results within three hours including DNA purification and no false-positive signals or cross-reactions were observed. Compared with culture, PCR detected 79 out of 81 C. jejuni (97.5%), 71 out of 74 Salmonella (96%), 8 out of 8 Shigella (100%), and 10 out of 10 Yersinia-positive (100%) clinical samples. In the 192 culture-negative samples, PCR additionally detected two Shigella, one Salmonella, and five C. jejuni infections. The authors concluded that real-time multiplex PCR provides reliable results within a short time and might be useful as an additional diagnostic tool whenever time is important in the diagnosis of enteropathogenic bacteria.

The approach presented in the study could be complemented with combinations of multiplex PCRs for the detection of other bacterial, parasitic, and viral infections to cover the entire spectrum of possible diarrhea-causing infectious agents. Integrated into clinical microbiology, these molecular tools may facilitate, accelerate, and optimize the diagnostic workflow. The study was available online on August 19, 2011, in the International Journal of Medical Microbiology.

Related Links:

Bernhard Nocht Institute
Qiagen





Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.